In VivoWalking through the halls of the St. Francis Westin Hotel during the J.P. Morgan Global Health Conference, one can’t help but notice the growing presence of East Asians. Yet, when it comes to the high
ScripBig Pharma’s global capability centers (GCCs) in India are evolving well beyond being just “cost efficiency outposts” and transitioning, in some cases, to emerge as centers of excellence (CoEs) unlock
ScripUnicycive Therapeutics was started by a single person, went public through an IPO in 2021, and four years later is preparing to continue its track record of proving skeptics wrong by independently lau
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C